EcoDrugPlus

Mapk Activated Protein Kinase 5

Ensembl ID : ENSEBUG00000000298
Gene Symbol: MAPKAPK5
1 Cross references
179 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSEBUG00000010972
Gene Symbol: NPC1L1
1 Cross references
190 Possible Orthologues:

Rho-Associated, Coiled-Coil Containing Protein Kinase 1

Ensembl ID : ENSEBUG00000016788
Gene Symbol: ROCK1
1 Cross references
208 Possible Orthologues:

Udp-Glucose Ceramide Glucosyltransferase

Ensembl ID : ENSEBUG00000012729
Gene Symbol: UGCG
1 Cross references
212 Possible Orthologues:

Activin A Receptor Type 2b

Ensembl ID : ENSEBUG00000014305
Gene Symbol: ACVR2B
1 Cross references
254 Possible Orthologues:

Adenosine A2a Receptor A

Ensembl ID : ENSEBUG00000013174
Gene Symbol: ADORA2AA
1 Cross references
461 Possible Orthologues:

Adrenoceptor Alpha 1b

Ensembl ID : ENSEBUG00000001801
Gene Symbol: ADRA1B
1 Cross references
265 Possible Orthologues:

Adrenoceptor Beta 1

Ensembl ID : ENSEBUG00000006164
Gene Symbol: ADRB1
1 Cross references
158 Possible Orthologues:

Aldo-Keto Reductase Family 1, Member B1 (Aldose Reductase), Tandem Duplicate 1

Ensembl ID : ENSEBUG00000011693
Gene Symbol: AKR1B1.1
1 Cross references
520 Possible Orthologues:

Apelin Receptor

Ensembl ID : ENSEBUG00000000460
Gene Symbol: APLNR
1 Cross references
344 Possible Orthologues:

Arachidonate 5-Lipoxygenase

Ensembl ID : ENSEBUG00000008636
Gene Symbol: ALOX5
1 Cross references
222 Possible Orthologues:

Arginine Vasopressin Receptor 1ab

Ensembl ID : ENSEBUG00000001467
Gene Symbol: AVPR1AB
1 Cross references
662 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).